Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Abdul-Hamid Bazarbachi"'
Autor:
Rayan Bou-Fakhredin, Abdul-Hamid Bazarbachi, Bachar Chaya, Joseph Sleiman, Maria Domenica Cappellini, Ali T. Taher
Publikováno v:
International Journal of Molecular Sciences, Vol 18, Iss 12, p 2778 (2017)
Iron overload (IOL) due to increased intestinal iron absorption constitutes a major clinical problem in patients with non-transfusion-dependent thalassemia (NTDT), which is a cumulative process with advancing age. Current models for iron metabolism i
Externí odkaz:
https://doaj.org/article/732c7a988aec4f789d1e61e88829cc02
Autor:
Razan Mohty, Rémy Dulery, Abdul Hamid Bazarbachi, Malvi Savani, Rama Al Hamed, Ali Bazarbachi, Mohamad Mohty
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 7, Pp 1-10 (2021)
Abstract Hodgkin lymphoma is a highly curable disease. Although most patients achieve complete response following frontline therapy, key unmet clinical needs remain including relapsed/refractory disease, treatment-related morbidity, impaired quality
Externí odkaz:
https://doaj.org/article/e64accd26ef44d47b4d3158c1ea5c9ba
Autor:
Rama Al Hamed, Abdul Hamid Bazarbachi, Ali Bazarbachi, Florent Malard, Jean-Luc Harousseau, Mohamad Mohty
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 5, Pp 1-13 (2021)
Abstract Amyloid light chain (AL) amyloidosis is among the more common and more severe of the amyloidoses usually involving the slow proliferation of a bone-marrow-residing plasma cell (PC) clone and the secretion of unstable immunoglobulin-free ligh
Externí odkaz:
https://doaj.org/article/b5d7840b9e4049a1afab39c91584966b
Autor:
Mehmet Kemal Samur, Mariateresa Fulciniti, Anil Aktas Samur, Abdul Hamid Bazarbachi, Yu-Tzu Tai, Rao Prabhala, Alejandro Alonso, Adam S. Sperling, Timothy Campbell, Fabio Petrocca, Kristen Hege, Shari Kaiser, Hervé Avet Loiseau, Kenneth C. Anderson, Nikhil C. Munshi
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-7 (2021)
Relapse following BCMA targeted CAR T-cell therapy is frequently observed in patients with multiple myeloma (MM). Here, by single cell transcriptome profiling on serially collected bone marrow samples, the authors report biallelic loss of BCMA as the
Externí odkaz:
https://doaj.org/article/d60d813fb4064441b48a7626818c3ce7
Autor:
Abdul-Hamid Bazarbachi, Daniel Reef, Hiba Narvel, Riya Patel, Rama Al Hamed, Sindhu Vikash, Karun Neupane, Eleftheria Atalla, Astha Thakkar, Shafia Rahman, Urvi Shah, Diego Adrianzen-Herrera, Ryann Quinn, Sumaira Zareef, Emma Rabinovich, Alyssa De Castro, Felisha Joseph, Kailyn Gillick, Jennat Mustafa, Fariha Khatun, Amanda Lombardo, Latoya Townsend-Nugent, Michelly Abreu, Nicole Chambers, Richard Elkind, Yang Shi, Yanhua Wang, Olga Derman, Kira Gritsman, Ulrich Steidl, Mendel Goldfinger, Noah Kornblum, Aditi Shastri, Ioannis Mantzaris, Liza Bachier-Rodriguez, Nishi Shah, Dennis Cooper, Amit Verma, Bihui Hilda Ye, Murali Janakiram, Roberto Alejandro Sica
Publikováno v:
Clinical Hematology International.
Adult T-cell leukemia/lymphoma (ATLL) remains challenging to treat and has dismal outcome. Allogeneic stem-cell transplantation (allo-SCT) has promising results, but data remain scarce. In this single-center retrospective analysis of 100 patients wit
Autor:
Abdul-Hamid Bazarbachi, Daniel K. Reef, Hiba Narvel, Riya Patel, Rama Al Hamed, Astha Thakkar, Shafia Rahman, Urvi A Shah, Diego Adrianzen Herrera, Ryann Quinn, Sumaira Zareef, Emma Rabinovich, Alyssa De Castro, Felisha Joseph, Kailyn Gillick, Jennat Mustafa, Fariha Khatun, Amanda Lombardo, Latoya Townsend Nugent, Michelly Abreu, Nicole Chambers, Richard Elkind, Yang Shi, Yanhua Wang, Olga Derman, Kira Gritsman, Ulrich Steidl, Mendel Goldfinger, Noah Kornblum, Aditi Shastri, Ioannis Mantzaris, Lizamarie Bachier Rodriguez, Nishi Shah, Dennis Cooper, Ira Braunschweig, Amit Verma, B. Hilda Ye, Murali Janakiram, R. Alejandro Sica
Publikováno v:
Blood. 140:662-664
Autor:
Tanim Jain, Abdul-Hamid Bazarbachi, Emma Rabinovich, Ahmed Abbasi, Kith Pradhan, Daniel K. Reef, Ryann Quinn, Hiba Narvel, Riya Patel, Rama Al Hamed, Astha Thakkar, Shafia Rahman, Alyssa De Castro, Felisha Joseph, Kailyn Gillick, Jennat Mustafa, Fariha Khatun, Amanda Lombardo, Latoya Townsend Nugent, Michelly Abreu, Nicole Chambers, Richard Elkind, Yang Shi, Yanhua Wang, Olga Derman, Xingxing Zang, Kira Gritsman, Ulrich G. Steidl, Mendel Goldfinger, Margaret McCort, Yoram Puius, Rachel Bartash, Noah Kornblum, Aditi Shastri, Ioannis Mantzaris, Lizamarie Bachier Rodriguez, Nishi Shah, Marina Konopleva, Christopher Nishimura, Dennis Cooper, Ira Braunschweig, Amit Verma, R. Alejandro Sica
Publikováno v:
Blood. 140:13225-13227
Autor:
Karun Neupane, Abdul-Hamid Bazarbachi, Daniel K. Reef, Kith Pradhan, Hiba Narvel, Alyssa De Castro, Felisha Joseph, Kailyn Gillick, Fariha Khatun, Amanda Lombardo, Yang Shi, Yanhua Wang, Kira Gritsman, Ulrich Steidl, Mendel Goldfinger, Noah Kornblum, Aditi Shastri, Ioannis Mantzaris, Lizamarie Bachier Rodriguez, Nishi Shah, Dennis Cooper, Ira Braunschweig, Amit Verma, Bin Hilda Ye, Marina Konopleva, R. Alejandro Sica
Publikováno v:
Blood. 140:11595-11597
Autor:
Mehmet Kemal Samur, Marco Roncador, Anil Aktas Samur, Mariateresa Fulciniti, Abdul Hamid Bazarbachi, Raphael Szalat, Masood A. Shammas, Adam S. Sperling, Paul G. Richardson, Florence Magrangeas, Stephane Minvielle, Aurore Perrot, Jill Corre, Philippe Moreau, Anjan Thakurta, Giovanni Parmigiani, Kenneth C. Anderson, Hervé Avet-Loiseau, Nikhil C. Munshi
Publikováno v:
Blood.
High-dose melphalan (HDM) improves progression-free survival in multiple myeloma (MM), yet melphalan is a DNA-damaging alkylating agent; therefore, we assessed its mutational effect on surviving myeloma cells by analyzing paired MM samples collected
Autor:
Mehmet Kemal Samur, Mohamad Mohty, Raphael Szalat, Abdul Hamid Bazarbachi, Nikhil C. Munshi, Steven P. Treon, Kenneth C. Anderson, Jill Corre, Zachary R. Hunter, Hervé Avet-Loiseau, Giovanni Parmigiani, Mariateresa Fulciniti, Masood A. Shammas, Anil Aktas Samur
Publikováno v:
Blood. 138:1980-1985
Immunoglobulin M (IgM) multiple myeloma (MM) is a rare disease subgroup. Its differentiation from other IgM-producing gammopathies such as Waldenström macroglobulinemia (WM) has not been well characterized but is essential for proper risk assessment